John has made over 2 trades of the resTORbio stock since 2016, according to the Form 4 filled with the SEC. Most recently John sold 1,399 units of TORC stock worth $2,938 on 14 February 2017.
The largest trade John's ever made was selling 1,399 units of resTORbio stock on 14 February 2017 worth over $2,938. On average, John trades about 285 units every 20 days since 2016. As of 14 February 2017 John still owns at least 5,930 units of resTORbio stock.
You can see the complete history of John Mccabe stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O RESTORBIO, INC., 500 BOYLSTON STREET, 13TH FLOOR, BOSTON, MA, 02116.
Over the last 7 years, insiders at resTORbio have traded over $9,290,741 worth of resTORbio stock and bought 1,305,999 units worth $19,553,525 . The most active insiders traders include Advisors Llc Orbi Med Capit..., Health Llc Pure Tech et Jonathan Silverstein. On average, resTORbio executives and independent directors trade stock every 69 days with the average trade being worth of $22,102,789. The most recent stock trade was executed by Health Llc Pure Tech on 18 December 2019, trading 6,161,531 units of TORC stock currently worth $7,393,837.
resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.
resTORbio executives and other stock owners filed with the SEC include: